Biotricity (BTCY) Competitors $0.54 0.00 (0.00%) As of 03:55 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainSEC FilingsTrendsBuy This Stock BTCY vs. WOK, MLSS, NMTC, MODD, TMDIF, POCI, PYPD, NEPH, COCH, and CLGNShould you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include WORK Medical Technology Group (WOK), Milestone Scientific (MLSS), NeuroOne Medical Technologies (NMTC), Modular Medical (MODD), Titan Medical (TMDIF), Precision Optics (POCI), PolyPid (PYPD), Nephros (NEPH), Envoy Medical (COCH), and CollPlant Biotechnologies (CLGN). These companies are all part of the "medical equipment" industry. Biotricity vs. Its Competitors WORK Medical Technology Group Milestone Scientific NeuroOne Medical Technologies Modular Medical Titan Medical Precision Optics PolyPid Nephros Envoy Medical CollPlant Biotechnologies Biotricity (NASDAQ:BTCY) and WORK Medical Technology Group (NASDAQ:WOK) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk. Which has better valuation & earnings, BTCY or WOK? WORK Medical Technology Group has lower revenue, but higher earnings than Biotricity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiotricity$12.06M1.12-$14.09M-$0.67-0.81WORK Medical Technology Group$11.51M3.86-$3.49MN/AN/A Is BTCY or WOK more profitable? WORK Medical Technology Group has a net margin of 0.00% compared to Biotricity's net margin of -80.42%. Company Net Margins Return on Equity Return on Assets Biotricity-80.42% N/A -188.47% WORK Medical Technology Group N/A N/A N/A Does the media favor BTCY or WOK? In the previous week, Biotricity had 3 more articles in the media than WORK Medical Technology Group. MarketBeat recorded 4 mentions for Biotricity and 1 mentions for WORK Medical Technology Group. WORK Medical Technology Group's average media sentiment score of 1.87 beat Biotricity's score of 0.19 indicating that WORK Medical Technology Group is being referred to more favorably in the news media. Company Overall Sentiment Biotricity Neutral WORK Medical Technology Group Very Positive Do analysts recommend BTCY or WOK? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biotricity 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00WORK Medical Technology Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in BTCY or WOK? 3.9% of Biotricity shares are owned by institutional investors. 10.1% of Biotricity shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. SummaryBiotricity and WORK Medical Technology Group tied by winning 5 of the 10 factors compared between the two stocks. Get Biotricity News Delivered to You Automatically Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTCY vs. The Competition Export to ExcelMetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$13.45M$78.71M$5.62B$9.84BDividend YieldN/AN/A4.61%4.07%P/E Ratio-0.5010.2130.2925.74Price / Sales1.1293.58463.41115.83Price / CashN/A18.4138.2159.48Price / Book-0.427.438.826.15Net Income-$14.09M-$26.39M$3.25B$265.06M7 Day Performance14.87%3.24%4.05%2.80%1 Month Performance31.84%4.82%4.32%1.68%1 Year Performance25.35%48.94%36.25%29.59% Biotricity Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTCYBiotricityN/A$0.54flatN/A+27.4%$13.45M$12.06M-0.5040News CoverageGap UpHigh Trading VolumeWOKWORK Medical Technology GroupN/A$0.80+3.9%N/AN/A$43.42M$11.51M0.00226Positive NewsGap UpMLSSMilestone Scientific2.3344 of 5 stars$0.53-3.8%$1.25+136.3%-41.0%$41.51M$8.61M-7.5630News CoverageShort Interest ↑High Trading VolumeNMTCNeuroOne Medical Technologies2.6582 of 5 stars$0.81-1.5%$1.45+78.8%+16.2%$41M$3.45M-3.6920News CoverageEarnings ReportGap UpMODDModular Medical0.6382 of 5 stars$0.71-4.6%N/A-55.9%$40.09MN/A-1.3820Earnings ReportGap UpHigh Trading VolumeTMDIFTitan MedicalN/A$0.33-7.1%N/A+929.1%$37.07M$17.63M-0.2650Gap DownPOCIPrecision Optics0.7725 of 5 stars$4.66-2.1%N/A-20.4%$36.47M$19.10M-5.2480Gap DownPYPDPolyPid3.0198 of 5 stars$3.37-2.0%$11.80+250.1%-0.9%$35.06MN/A-0.7880Trending NewsEarnings ReportAnalyst ForecastShort Interest ↓NEPHNephros2.422 of 5 stars$3.10-4.3%$5.00+61.3%+118.0%$34.35M$14.16M44.2930Earnings ReportHigh Trading VolumeCOCHEnvoy Medical3.4578 of 5 stars$1.48+3.5%$9.25+525.0%-42.6%$30.50M$220K-1.0334CLGNCollPlant Biotechnologies2.8907 of 5 stars$2.25flat$11.50+411.1%-39.3%$28.58M$510K-1.8470News CoverageUpcoming Earnings Related Companies and Tools Related Companies WORK Medical Technology Group Alternatives Milestone Scientific Alternatives NeuroOne Medical Technologies Alternatives Modular Medical Alternatives Titan Medical Alternatives Precision Optics Alternatives PolyPid Alternatives Nephros Alternatives Envoy Medical Alternatives CollPlant Biotechnologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTCY) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotricity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotricity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access